Clinical Trial Update: A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase I trial evaluating the combination of mFOLFOX6, Avastin (bevacizumab), and Nexavar (sorafenib) as first-line therapy for metastatic colorectal cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• MFOLFOX6
• Nexavar (Sorafenib)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: TERMINATED | Results posted: 2011-10-26